Sight Sciences, Inc.
SGHT$221M
Micro CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaMENLO PARK
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Dec 30, 2026
41wMarket Overview
Stock performance and key metrics
SGHT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BS01 | Phase 2 | Retinitis Pigmentosa | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply